Navigation Links
Cayenne Medical, Inc. Launches AperFix® II
Date:2/15/2011

SCOTTSDALE, Ariz., Feb. 15, 2011 /PRNewswire/ -- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of AperFix® II, its second generation soft tissue repair device for multi-ligament repairs of the knee. The announcement was made today at the 2011 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Diego, CA.  

Key to AperFix II is the introduction of its new Cannulated Tibial System, which provides surgeons with increased ease-of-insertion and standardized positioning of the implant. For anterior cruciate ligament (ACL) repair, the system allows for rotation of the two tendons representing the anteromedial (AM) and posterolateral (PL) bundles to more accurately match the positioning of the native ACL bundles. Additionally, new enhancements to the femoral device allow for easier graft insertion and placement within the tunnel.

"The AperFix II System offers a simple and efficient technique to obtain consistent circumferential graft compression, restoring native knee kinematics," said Kenneth Montgomery MD, orthopedic surgeon, Tri-County Orthopaedic & Sports Medicine, Morristown, NJ.  "I believe this procedural enhancement will ensure the integrity and strength of the reconstructed ligament, providing patients with a more stable knee."

The addition of the Cannulated Tibial System, along with enhancements to the femoral device, serve to strengthen Cayenne Medical's innovative AperFix ligament reconstruction technology, which utilizes a single tunnel, all-inside approach for attaching the soft tissue graft at the aperture of the femoral and tibial tunnels. This technique creates a shorter, stiffer and more anatomic ligament repair.  

"As the industry continues to lean in favor of soft tissue ligament reconstruction, we have seen much success with our flagship product AperFix and an increasing interest in its anatomic repair through aperture graft fixation," said James W. Hart, Executive Chairman, Cayenne Medical. "The strategic enhancements we've made to the tibial portion of the procedure with AperFix II are in line with this trend and affirm our commitment to evolving our technology platform for the benefit of surgeons and their patients."

The AperFix II Cannulated Tibial System includes the tibial implant made from PEEK polymer, a tendon expander, a guide wire, a cannulated screw and a driver pre-loaded with tibial sheaths and a sheath holder.

AperFix II is available for demonstration at the Cayenne Medical AAOS Booth (#406) and is available to surgeons upon request ahead of the upcoming commercial rollout.

Cayenne Medical also markets CrossFix® Meniscal Repair System for the treatment of repairable traumatic meniscal tears and the iFix® System for bone-tendon-bone ACL reconstruction. For more information about AperFix® II or Cayenne Medical, please visit www.cayennemedical.com.

About Cayenne Medical, Inc.:Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional ACL, PCL and meniscal repair procedures, by applying advanced technology through minimally invasive techniques. For more information, visit www.cayennemedical.com.Contacts:Tim Nash

Kimberly Muscara(480) 502-3661

(646) 536-7011/(973) 768-0449tnash@cayennemedical.com

kmuscara@theruthgroup.com
'/>"/>

SOURCE Cayenne Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
2. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
3. Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark
4. Kips Bay Medical, Inc. Announces Pricing of its Initial Public Offering of Common Stock
5. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
6. Nonin Medical, Inc. Launches New WristOx2™, Model 3150 in U.S. and Canada
7. Kevin Banion Named CEO of Progressive Medical, Inc.
8. Solta Medical, Inc. Appoints Thomas J. Yorkey, Ph.D. to Vice President of Research & Development
9. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
10. Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
11. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ ... Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - ... reach USD 779.8 Million by 2021 from USD 414.6 Million in ... of 2016 to 2021. Continue Reading ... ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 According ... by Product Type and by Application - Global Opportunity Analysis and Industry Forecast, ... 2015, and is expected to reach $5,255 million by 2022, growing at a ... in 2015 with more than four-fifths share. Continue ... ...
(Date:12/5/2016)... and PUNE, India , December ... report by Allied Market Research, titled, "Global Cancer Biomarkers Market ... revenue of cancer biomarkers market is projected to reach $15,737 ... CAGR of 13.3% from 2016 to 2022. Omic technologies segment ... 2015 and is expected to maintain its dominance during the ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 hardcover ... Lithuanian language and its poetry inspired him in writing “ Forest Lungs ... aspects of a living, breathing forest where nothing ever stays the same. His subjects ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced today that nominations will be accepted from December 5, 2016 through ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:12/5/2016)... ... December 05, 2016 , ... Worldwise ... global lifestyle design firm kathy ireland® Worldwide for five additional years, announced by ... into an exclusive licensing agreement three years ago to design and develop the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ICA, ... alerting technology to Central Illinois Health Information Exchange (CIHIE) using its Smart ... as the sole sub-recipient participating with the Illinois Health Information Exchange Authority ...
Breaking Medicine News(10 mins):